TGFB1 and Myocardial fibrosis: The present experiments demonstrated that ginsenoside Rg2 possesses the property of alleviating myocardial fibrosis and improving cardiac function by regulating the TGF-β1/Smad signalling pathway after myocardial ischaemia.